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A Shocking Case of Far-Field Atrial
Oversensing in Giant-Cell Myocarditis
Tanuka Datta, MD, Stephen Melnick, DO, Bharaniabirami Rajaram, MD, Behzad B. Pavri, MD

ABSTRACT
We report a unique case of delivery of inappropriate implantable cardioverter-deﬁbrillator therapies related to a “perfect
storm”: presence of an integrated lead, insufﬁcient lead slack related to right heart dilation resulting in shock coil
misplacement, myocarditis with loss of R waves, and the concomitant occurrence of an incessant atrial tachycardia.
(Level of Difﬁculty: Advanced.) (J Am Coll Cardiol Case Rep 2021;3:603–9) © 2021 The Authors. Published by Elsevier
on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

HISTORY OF PRESENTATION

ventricle, even when fully unloaded by the left
ventricular assist device with normal ﬂows, was

A 35-year-old male with a history of nonischemic

barely contractile. The right ventricle was also

cardiomyopathy from giant-cell myocarditis (GCM)

severely dilated and hypokinetic, suggesting single-

with a HeartMate 3 left ventricular assist device

ventricle physiology with the right ventricle acting

(Abbott Cardiovascular, Plymouth, Minnesota) and a

as a passive conduit. Telemetry and electrocardio-

cardioverter-

graphic review showed an atypical atrial ﬂutter or

deﬁbrillator (VIGILANT EL ICD D232/254693, Bos-

atrial tachycardia with predominantly 2:1 atrioven-

ton Scientiﬁc, Marlborough, Massachusetts) pre-

tricular block (Figures 1A and 1B).

single-chamber

implantable

sented after receiving a shock. His vital signs
showed blood pressure of 110/89 mm Hg, pulse of
69 beats/min, and oxygen saturation of 99% on
room air. Echocardiography showed that his left

DIFFERENTIAL DIAGNOSIS
The differential diagnosis for shock therapy included
ventricular tachycardia (VT), ventricular ﬁbrillation

LEARNING OBJECTIVES
 To describe clinical scenarios during which
atrial oversensing occurs.
 To recognize the scenario of oversensing of
far-ﬁeld atrial signals during atrial
tachycardia.
 To identify the mechanism of marked reduction in ventricular sensed amplitudes in the
setting of myocarditis.

(VF), and inappropriate sensing.

INVESTIGATIONS
Interrogation revealed device programming for VVI
pacing at 40 beats/min. Tachytherapies were programmed in 2 zones: VT at 200 beats/min (10 s) and
VF at 220 beats/min (2.5 s). Therapies for arrhythmias
in the VT zone were programmed to 2 rounds of
antitachycardia pacing (ATP) followed by 36-J shocks;
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ABBREVIATIONS

therapies for arrhythmias in the VF zone

AND ACRONYMS

were programmed for 1 try of ATP followed

ATP = antitachycardia pacing
GCM = giant-cell myocarditis
RV = right ventricular

MANAGEMENT

by shocks. The device logs showed that the

In the setting of GCM, the progressive reduction in R-

patient had experienced 38 episodes of “VT,”

wave amplitudes was likely due to direct involvement

with 22 episodes triggering ATP and 3 epi-

of the myocardial tissue in the right ventricle, where

sodes resulting in shocks; all treated episodes

his deﬁbrillator lead was located, because of disease

VF = ventricular ﬁbrillation

were declared to have “successful termina-

progression. Furthermore, Boston Scientiﬁc deﬁbril-

VT = ventricular tachycardia

tion” (Figure 2), all occurring over a short

lator leads have an integrated bipolar conﬁguration;

time period. The stored intracardiac trends disclosed

right ventricular (RV) dilation and the septal lead po-

that over the preceding 2 months, as his steroids were

sition (placed at an outside hospital) likely contributed

tapered, the sensed R-wave amplitude had dimin-

to the insufﬁcient slack seen on chest radiography,

ished to the point at which the deﬁbrillator was no

resulting in the proximal end of the shocking coil (used

longer able to sense native R waves even at maximum

as the anode for sensing) being in the right atrium

autogain (Figure 3). However, the far-ﬁeld atrial

(Figure 4). The automatic sensing threshold of his

electrograms during ongoing atrial tachycardia were

deﬁbrillator had dropped down to the lowest level

sensed by the integrated deﬁbrillator lead, leading to

because of small native QRS complexes, which resul-

delivery of inappropriate therapies.

ted in detection of atrial signals during the ongoing

F I G U R E 1 Telemetry and Electrocardiography of Atypical Atrial Flutter

(A) Telemetry showing 2:1 atrial tachycardia. Visible atrial deﬂections are marked with arrows; atrial rate is about 210 to 220 beats/min. (B) 12-Lead electrocardiogram
showing atypical atrial ﬂutter with 2:1 atrioventricular conduction; atrial rate is approximately 216 beats/min, and ventricular rate is about 108 beats/min. Electrocardiogram is displayed at twice gain with 20-Hz ﬁlter applied.
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F I G U R E 2 Device Interrogation Report Showing Ventricular Episodes

atrial tachycardia at a rate of approximately 210 beats/

atrial tachycardia, the device was completely deac-

min (Figure 5). This arrhythmia was detected as “VT,”

tivated

resulting in inappropriate ATP followed by a shock,

therapies.

for

both

tachycardia

and

bradycardia

terminating the atrial tachycardia brieﬂy.
We tested for true R-wave sensing at maximum

DISCUSSION

sensitivity of 0.15 mV, but the device continued to
sense only atrial signals. In the setting of inability

Inappropriate shocks can be the result of oversensing

to detect true R waves, and inappropriate shocks

atrial depolarization during an atrial arrhythmia such

due to far-ﬁeld atrial oversensing during incessant

as ﬂutter or tachycardia (1–3). Clinical scenarios in

F I G U R E 3 Progressively Diminishing R-Wave Amplitude Prior to Hospitalization
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F I G U R E 4 Implantable Cardioverter-Deﬁbrillator Lead With Insufﬁcient Slack and

Proximal End of Shocking Coil Positioned in the Right Atrium

which these occur are summarized in Table 1 (4–6). RV
lead positioning becomes especially important with
integrated bipolar leads; placement in the RV apex
with the distal coil lying entirely within the RV cavity
will minimize the probability of atrial oversensing
(7,8). Remote monitoring has the potential to recognize early changes and potentially prevent such outcomes (9).

FOLLOW-UP
The patient successfully underwent heart transplantation in the following months and is doing well
clinically.

CONCLUSIONS
Inappropriate shocks in the setting of inﬂammatory
cardiomyopathy can be the result of disease progression as well as RV lead factors such as bipolar
conﬁgurations and lead placement. Cardiologists
must be able to distinguish between true VT and
inappropriate sensing of atrial arrythmias in this
unique setting.

FUNDING SUPPORT AND AUTHOR DISCLOSURES
Arrow denotes proximal end of shocking coil positioned in the right atrium.
The authors have reported that they have no relationships relevant to
the contents of this paper to disclose.

F I G U R E 5 Intracardiac Signals From Device Interrogation

Intracardiac far-ﬁeld signals (top trace) and near-ﬁeld electrograms from the integrated right ventricular lead (bottom trace). No right ventricular signals are visually
evident on the near-ﬁeld electrograms; a small far-ﬁeld R-wave is intermittently visible (arrows).
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T A B L E 1 Clinical Scenarios During Which Atrial Oversensing Occurs

Cause of Oversensing

Image

First Author
(Ref. #)

RV lead–only devices
Lead dislodgement to the atrium or atrioventricular junction

Brüggemann
et al. (4)

Integrated bipolar lead positioning near tricuspid annulus

Kossaify (5)

Unintentional lead implantation into coronary sinus

Gunderson
et al. (6)

Continued on the next page
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T A B L E 1 Continued

Cause of Oversensing

Image

Insulation defect in atrial portion of the lead causing sensing of atrial activity

First Author
(Ref. #)

Gunderson
et al. (6)

Dual-chamber devices
Gunderson
et al. (6)

Atrial lead to RV lead interaction with the atrial lead contacting the RV lead during
atrial systole, thereby producing a signal that is sensed by the RV lead
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